Literature DB >> 32324205

Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials.

Rafael Dal-Ré1, Aaron S Kesselheim2, Florence T Bourgeois3,4.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32324205     DOI： 10.1001/jama.2020.1631

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?

Authors:  Rosemarie D L C Bernabe; Ghislaine J M W van Thiel; Nancy S Breekveldt; Christine C Gispen; Johannes J M van Delden
Journal:  BMC Med Ethics       Date:  2020-10-27       Impact factor: 2.652
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.